Home > Financial Ratios > ANUH PHARMA

ANUH PHARMA
Core EBITDA Growth

    Back to All Ratios
ANUH PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ANUH PHARMA
Please provide your vote to see the results

ANUH PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -6.24-19.2051.689.98-5.38

What is the latest Core EBITDA Growth ratio of ANUH PHARMA ?

The latest Core EBITDA Growth ratio of ANUH PHARMA is -6.24 based on Mar2026 Standalone results.
Year Core EBITDA Growth
Mar2026-6.24
Mar2025-19.20
Mar202451.68
Mar20239.98
Mar2022-5.38

How is Core EBITDA Growth of ANUH PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2026 -6.24
Negative
Mar2025 -19.2
Negative
Mar2024 51.68
417.84
Mar2023 9.98
Positive
Mar2022 -5.38 -

Other Financial Ratios of ANUH PHARMA


Compare Core EBITDA Growth ratio of peers of ANUH PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ANUH PHARMA ₹942.2 Cr 3.7% 22.6% 5.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,437.0 Cr 1.8% -1.7% 14.6% Stock Analytics
DIVIS LABORATORIES ₹248,054.0 Cr 2.6% 9.8% 54.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,842.0 Cr 2.4% -0.5% 36% Stock Analytics
CIPLA ₹111,565.0 Cr 1.8% -3.7% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹101,163.0 Cr 4.5% 1.8% -10% Stock Analytics


ANUH PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ANUH PHARMA

3.7%

22.6%

5.7%

SENSEX

0.7%

-3.9%

-8.9%


You may also like the below Video Courses